Qianjiang Yongan Pharmaceutical Co Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Qianjiang Yongan Pharmaceutical Co Ltd with three other
companies in this sector in CHINA :
Huaren Pharmaceutical Co Ltd
sales of 1.46 billion Chinese Renmimbi [US$215.88 million]
of which 91%
was Medicine Industry),
CSPC Innovation Pharmaceutical Co Ltd
(1.26 billion Chinese Renmimbi [US$185.55 million]
of which 69%
was Caffeine Division), and
Tibet Cheezheng Tibetan Medicine Co Ltd
(1.40 billion Chinese Renmimbi [US$207.13 million]
of which 100%
During the year ended December of 2019, sales at
Qianjiang Yongan Pharmaceutical Co Ltd were 1.37 billion Chinese Renmimbi (US$202.37 million).
increase of 36.3%
versus 2018, when the company's sales were 1.01 billion Chinese Renmimbi.
This was the third consecutive year of growth at Qianjiang Yongan Pharmaceutical Co Ltd.
Sales of Healthy Food Products saw an increase
46.6% in 2019, from
68.42 million Chinese Renmimbi to 100.28 million Chinese Renmimbi.
Not all segments of Qianjiang Yongan Pharmaceutical Co Ltd experienced an increase in sales in 2019:
sales of Other Main Business fell 93.6% to 10.54 million Chinese Renmimbi.
Qianjiang Yongan Pharmaceutical Co Ltd also experienced decreases in sales in
Medical Manufacturing (down 25.7% to 573.84 million Chinese Renmimbi)